321 related articles for article (PubMed ID: 32651179)
21. TP53 alterations of hormone-naïve prostate cancer in the Chinese population.
Liu Z; Guo H; Zhu Y; Xia Y; Cui J; Shi K; Fan Y; Shi B; Chen S
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):482-491. PubMed ID: 33214693
[TBL] [Abstract][Full Text] [Related]
22. An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer.
Dawson NA; Zibelman M; Lindsay T; Feldman RA; Saul M; Gatalica Z; Korn WM; Heath EI
Mol Cancer Ther; 2020 Jun; 19(6):1373-1382. PubMed ID: 32220973
[TBL] [Abstract][Full Text] [Related]
23. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
24. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
[TBL] [Abstract][Full Text] [Related]
25. Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions.
Chalmers ZR; Burns MC; Ebot EM; Frampton GM; Ross JS; Hussain MHA; Abdulkadir SA
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):558-566. PubMed ID: 33420417
[TBL] [Abstract][Full Text] [Related]
26. Copy number and gene expression differences between African American and Caucasian American prostate cancer.
Rose AE; Satagopan JM; Oddoux C; Zhou Q; Xu R; Olshen AB; Yu JZ; Dash A; Jean-Gilles J; Reuter V; Gerald WL; Lee P; Osman I
J Transl Med; 2010 Jul; 8():70. PubMed ID: 20649978
[TBL] [Abstract][Full Text] [Related]
27. Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.
Marima R; Hull R; Mbeje M; Molefi T; Mathabe K; Elbagory AM; Demetriou D; Dlamini Z
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054814
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.
Rayford W; Beksac AT; Alger J; Alshalalfa M; Ahmed M; Khan I; Falagario UG; Liu Y; Davicioni E; Spratt DE; Schaeffer EM; Feng FY; Mahal B; Nguyen PL; Den RB; Greenberger MD; Bradley R; Watson JM; Beamer M; Stamatakis L; Carmen DJ; Awasthi S; Hwang J; Weil R; Merisaari H; Mohamed N; Deane LA; Chakravarty D; Yadav KK; Yamoah K; Nair SS; Tewari AK
Commun Biol; 2021 Jun; 4(1):670. PubMed ID: 34083737
[TBL] [Abstract][Full Text] [Related]
29. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
30. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
Beltran H; Yelensky R; Frampton GM; Park K; Downing SR; MacDonald TY; Jarosz M; Lipson D; Tagawa ST; Nanus DM; Stephens PJ; Mosquera JM; Cronin MT; Rubin MA
Eur Urol; 2013 May; 63(5):920-6. PubMed ID: 22981675
[TBL] [Abstract][Full Text] [Related]
31. TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: A focus on Africa.
Blackburn J; Vecchiarelli S; Heyer EE; Patrick SM; Lyons RJ; Jaratlerdsiri W; van Zyl S; Bornman MSR; Mercer TR; Hayes VM
Prostate; 2019 Jul; 79(10):1191-1196. PubMed ID: 31090091
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians.
Yadav S; Anbalagan M; Baddoo M; Chellamuthu VK; Mukhopadhyay S; Woods C; Jiang W; Moroz K; Flemington EK; Makridakis N
Oncogene; 2020 May; 39(21):4299-4311. PubMed ID: 32300177
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis for prostate cancer racial disparities.
Singh SK; Lillard JW; Singh R
Front Biosci (Landmark Ed); 2017 Jan; 22(3):428-450. PubMed ID: 27814623
[TBL] [Abstract][Full Text] [Related]
34. Genes associated with prostate cancer are differentially expressed in African American and European American men.
Powell IJ; Dyson G; Land S; Ruterbusch J; Bock CH; Lenk S; Herawi M; Everson R; Giroux CN; Schwartz AG; Bollig-Fischer A
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):891-7. PubMed ID: 23515145
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects.
Frank S; Nelson P; Vasioukhin V
F1000Res; 2018; 7():. PubMed ID: 30135717
[TBL] [Abstract][Full Text] [Related]
36. Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
Kotecha RR; Knezevic A; Arora K; Bandlamudi C; Kuo F; Carlo MI; Fitzgerald KN; Feldman DR; Shah NJ; Reznik E; Hakimi AA; Carrot-Zhang J; Mandelker D; Berger M; Lee CH; Motzer RJ; Voss MH
Cancer; 2024 Mar; 130(5):692-701. PubMed ID: 37864521
[TBL] [Abstract][Full Text] [Related]
37. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
38. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
[TBL] [Abstract][Full Text] [Related]
39. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH
BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717
[TBL] [Abstract][Full Text] [Related]
40. Copy Number Profiles of Prostate Cancer in Men of Middle Eastern Ancestry.
Albawardi A; Livingstone J; Almarzooqi S; Palanisamy N; Houlahan KE; Awwad AAA; Abdelsalam RA; Boutros PC; Bismar TA
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
